CerFlux, Inc.
Personalized Oncology Efficacy Test (POET) — a low-cost, rapid in vitro diagnostic platform using pancreatic microtissue tumor models to predict individual patient response to systemic therapy regimen
- Sector
- Medtech
- Headquarters
- Birmingham, AL
- Founded
- 2018
- Latest Form D
- $880K offered, Feb 2020
- Total capital
- $1.5M
- Federal grants
- $628K
- 3 awards · 2020–2023
- Rank in peer group#23 of 79
- Private capital raised
- $880K
- 1 Form D · last Feb 2020
- 80 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 2
- 2 pending · first 2021
- Rank in peer group#12 of 79
Capital timeline
Latest events
- Federal grantNSF · Phase I · SBIR Phase I: Predictive ex vivo solid tumor biopsy-chip multiplexer for screening anticancer agents$275K
- Federal grantHealth and Human S · Phase I · Development of personalized ex vivo predictive technology for rapidly matching patient tumors with chemotherapy regimens before treatment.$52K
- Federal grantHealth and Human S · Phase I · Development of personalized ex vivo predictive technology for rapidly matching patient tumors with chemotherapy regimens before treatment.$301K
- Offering registeredForm D · SEC · 1st filing$880K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 79 peers
Line = medianMedtech · Instrument
- Federal grants#23 · top 29%
- Granted patents#12 · top 15%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Karim I. BudhwaniResearcherExecutive Officer, DirectorLinked by 2 patents · $628K in grants as PI
What it has protected
USPTO · 2 granted of 4- PendingBiomimetic Array Device And Methods Of Using SameUSPTOApplication 18528714
- GrantedBiomimetic Array Device And Methods Of Using SameUSPTOUS 11,833,514
- GrantedBiomimetic Array Device And Methods Of Using SameUSPTOUS 11,097,274
Show all 4 patent records
- Biomimetic Array Device And Methods Of Using SameMar 28, 2024 · Application 18528714Pending
- Biomimetic Array Device And Methods Of Using SameDec 5, 2023 · US 11,833,514Granted
- Biomimetic Array Device And Methods Of Using SameAug 24, 2021 · US 11,097,274Granted
- Biomimetic Array Device And Methods Of Using SameApplication PCTUS2019067969Pending
Related companies, and why
- BRITESEED, LLCSimilar federal contract value in Medtech · null in contracts
- KILELE HEALTH INC.Similar federal contract value in Medtech · null in contracts
- HEALING INNOVATIONS INCSimilar federal contract value in Medtech · null in contracts
- NEUROLOGICAL REHABILITATION VIRTUAL REALITY, L.L.C.Similar federal contract value in Medtech · null in contracts
- Sanguina, LLCSimilar federal contract value in Medtech · null in contracts
- Neptune Fluid Flow Systems LLCSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .